PUK13 COST-EFFECTIVENESS ANALYSIS OF THE EARLY CONVERSION OF TACROLIMUS TO MTOR INHIBITORS IN PATIENTS WITH RENAL TRANSPLANTATION
May 1, 2011, 00:00 AM
10.1016/j.jval.2011.02.428
https://www.valueinhealthjournal.com/article/S1098-3015(11)00567-5/fulltext
Section Title :
Disease-Specific Studies
Section Order :
988
First Page :
A76
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)00567-5&doi=10.1016/j.jval.2011.02.428